These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37874837)

  • 81. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Phenotypic and Genotypic Characterization of Multidrug-Resistant Enterobacter hormaechei Carrying
    Cao Z; Cui L; Liu Q; Liu F; Zhao Y; Guo K; Hu T; Zhang F; Sheng X; Wang X; Peng Z; Dai M
    Microbiol Spectr; 2022 Jun; 10(3):e0251821. PubMed ID: 35467399
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Enterobacter cloacae: a villain in CaOx stone disease?
    Yang Y; Hong S; Xu J; Li C; Wang S; Xun Y
    Urolithiasis; 2022 Apr; 50(2):177-188. PubMed ID: 35124708
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Bacteriophages PɸEn-CL and PɸEn-HO can eliminate MDR Enterobacter cloacae and Enterobacter hormaechei isolated from burn wound infections without toxicity for human skin cells.
    Rahimzadeh Torabi L; Doudi M; Naghavi NS; Monajemi R
    FEMS Microbiol Lett; 2021 Nov; 368(20):. PubMed ID: 34849758
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Antiadhesive hydroalcoholic extract from Apium graveolens fruits prevents bladder and kidney infection against uropathogenic E. coli.
    Sarshar S; Sendker J; Qin X; Goycoolea FM; Asadi Karam MR; Habibi M; Bouzari S; Dobrindt U; Hensel A
    Fitoterapia; 2018 Jun; 127():237-244. PubMed ID: 29496563
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
    Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
    [TBL] [Abstract][Full Text] [Related]  

  • 87. High prevalence of colistin heteroresistance in specific species and lineages of Enterobacter cloacae complex derived from human clinical specimens.
    Fukuzawa S; Sato T; Aoki K; Yamamoto S; Ogasawara N; Nakajima C; Suzuki Y; Horiuchi M; Takahashi S; Yokota SI
    Ann Clin Microbiol Antimicrob; 2023 Jul; 22(1):60. PubMed ID: 37454128
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Emergence and Spread of Carbapenem-Resistant and Aminoglycoside-Panresistant
    Oshiro S; Tada T; Watanabe S; Tohya M; Hishinuma T; Uchida H; Kuwahara-Arai K; Mya S; Zan KN; Kirikae T; Tin HH
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32161144
    [TBL] [Abstract][Full Text] [Related]  

  • 89. High-risk international clones ST66, ST171 and ST78 of Enterobacter cloacae complex causing blood stream infections in Spain and carrying bla
    Lumbreras-Iglesias P; de Toro M; Vázquez X; García-Carús E; Rodicio MR; Fernández J
    J Infect Public Health; 2023 Feb; 16(2):272-279. PubMed ID: 36621205
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Urinary tract infections in the early posttransplant period after kidney transplantation: etiologic agents and their susceptibility.
    Kawecki D; Kwiatkowski A; Sawicka-Grzelak A; Durlik M; Paczek L; Chmura A; Mlynarczyk G; Rowinski W; Luczak M
    Transplant Proc; 2011 Oct; 43(8):2991-3. PubMed ID: 21996207
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
    Hansen GT; Blondeau JM
    J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae.
    Pérez A; Poza M; Fernández A; Fernández Mdel C; Mallo S; Merino M; Rumbo-Feal S; Cabral MP; Bou G
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2084-90. PubMed ID: 22290971
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Neonatal infections with multidrug-resistant ESBL-producing E. cloacae and K. pneumoniae in Neonatal Units of two different Hospitals in Antananarivo, Madagascar.
    Naas T; Cuzon G; Robinson AL; Andrianirina Z; Imbert P; Ratsima E; Ranosiarisoa ZN; Nordmann P; Raymond J
    BMC Infect Dis; 2016 Jun; 16():275. PubMed ID: 27287441
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Irreproducible and uninterpretable Polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenes.
    Landman D; Salamera J; Quale J
    J Clin Microbiol; 2013 Dec; 51(12):4106-11. PubMed ID: 24088860
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1991). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Oct; 48(10):1394-421. PubMed ID: 8544337
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Modification of rock/fluid and fluid/fluid interfaces during MEOR processes, using two biosurfactant producing strains of Bacillus stearothermophilus SUCPM#14 and Enterobacter cloacae: a mechanistic study.
    Sarafzadeh P; Zeinolabedini Hezave A; Mohammadi S; Niazi A; Ayatollahi S
    Colloids Surf B Biointerfaces; 2014 May; 117():457-65. PubMed ID: 24373916
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Extract of Clinopodium bolivianum protects against E. coli invasion of uroepithelial cells.
    Mohanty S; Kamolvit W; Zambrana S; Sandström C; Gonzales E; Östenson CG; Brauner A
    J Ethnopharmacol; 2017 Feb; 198():214-220. PubMed ID: 28087472
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model.
    Abbott IJ; Meletiadis J; Belghanch I; Wijma RA; Kanioura L; Roberts JA; Peleg AY; Mouton JW
    J Antimicrob Chemother; 2018 Mar; 73(3):709-719. PubMed ID: 29253153
    [TBL] [Abstract][Full Text] [Related]  

  • 99. In vitro evaluation of biofilm formation by Candida parapsilosis and Enterobacter cloacae. Scanning electron microscopy and efficacy of antimicrobial combinations study.
    Benahmed A; Seghir A; Boucherit-Otmani Z; Tani ZZBA; Aissaoui M; Kendil W; Merabet DH; Lakhal H; Boucherit K
    Diagn Microbiol Infect Dis; 2023 Sep; 107(1):116003. PubMed ID: 37423195
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Exploring Cluster-Dependent Antibacterial Activities and Resistance Pathways of NOSO-502 and Colistin against Enterobacter cloacae Complex Species.
    Pantel L; Guérin F; Serri M; Gravey F; Houard J; Maurent K; Attwood M; Noel A; MacGowan A; Racine E; Cattoir V; Gualtieri M
    Antimicrob Agents Chemother; 2022 Nov; 66(11):e0077622. PubMed ID: 36200761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.